ArticleMemorias do Instituto Oswaldo Cruz2025
IgY antibodies/Cysteamine: simple and effective methodology for electrochemical detection of SARS-CoV-2 S-protein.
Article in Memorias do Instituto Oswaldo Cruz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections was a serious disease that spread rapidly around the world and led to a state of global health emergency. During the pandemic, millions of deaths were notified as result of the progression of the disease to a serious condition. Research into the development of diagnostic tests was very important for the identification and control of new cases.
objectivesIn this work a label-free electrochemical platform was developed for sensing of SARS-CoV-2 S-protein.
methodsThe S- antibodies (IgY type) from egg yolk were immobilised though stable bonding onto screen-printed gold electrodes surface, which was previously modified with self-assembled monolayers of cysteamine (Cys). The analytical performance of the devices was followed by differential pulse voltammetry after incubation in various concentrations of S-protein.
findingsThe electrical response exhibited a linear behaviour from 10 to 1000 ng mL-1 [with limit of detection (LOD) of 6.2 ng mL-1]. Also, we confirmed that our method is more sensitive than an enzyme-linked immuno-sorbent assay (ELISA), which was conducted with the same molecules (antibody and antigen) (500-4000 ng mL-1, with LOD = 235 ng mL-1). The immunosensor was selective for S-protein detection, and no significative changes were registered by differential pulse voltammetry in presence of SARS-CoV-2 N-protein. Tests on saliva samples recorded similar results to S protein standards. MAIN
conclusionsThe developed immunosensor showed good performance and selectivity, therefore, it can be an alternative method for coronavirus disease 2019 (Covid-19) detecting in saliva samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.